Commentary to Ocular dysmotility after SARS-CoV-2 vaccination requires the exclusion of all differential causes
Graefes Arch Clin Exp Ophthalmol
.
2023 Jun;261(6):1767-1768.
doi: 10.1007/s00417-023-05992-8.
Epub 2023 Feb 15.
Authors
Kyung-Ah Park
#
1
,
Hyeshin Jeon
#
2
,
Dong Gyu Choi
3
,
Jae Ho Jung
4
Affiliations
1
Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
2
Department of Ophthalmology, Pusan National University College of Medicine and Biomedical Research Institute, Busan, Korea.
3
Department of Ophthalmology, Kangnam Sacred Heart Hospital, College of Medicine Hallym University, Chuncheon, Korea. eyechoi602@gmail.com.
4
Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.
#
Contributed equally.
PMID:
36790679
PMCID:
PMC9930704
DOI:
10.1007/s00417-023-05992-8
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Viral
COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Ocular Motility Disorders*
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines
Antibodies, Viral